Biotech
> Cheryl Cohen, former Medivation ($MDVN) chief commercial officer, joined Vital Therapies' ($VTL) board of directors. Release
> Galectin Therapeutics ($GALT) appointed Adam Allgood as executive director of clinical development. Release
> Dr. Charles Richard joined uniQure ($QURE) as senior vice president of research and development, neuroscience. Release
> Algorithme Pharma named Anahita Keyhani as director of method development. Release
> Highland Therapeutics appointed Thomas Curatolo as executive vice president of commercial strategy & operations and Rick Nullmeier as vice president of marketing. Release
> Aeras COO Jacqueline Shea will take over as CEO on Aug. 12. Current CEO Dr. Thomas Evans will step down and serve as acting chief scientific officer. Release
> Rigontec named Donald deBethizy as chairman of its board. Release
> Fate Therapeutics ($FATE) appointed Stewart Abbot as vice president of translational research. Release
> Raptor Pharmaceutical ($RPTP) appointed Ashley Gould as senior vice president, general counsel and corporate governance. Chief Business Officer Ted Daley will leave the company in September. Release
> Histogenics ($HSGX) named Dr. Gloria Matthews as chief medical officer. Release
> TetraPhase Pharmaceuticals ($TTPH) appointed Jacques Dumas as chief scientific officer. Release
> Motif Bio added Dr. Tom File to its scientific advisory board. Release
> Dr. Robin David Isaacs joins Entasis Therapeutics as chief medical officer. Release
> ERYtech Pharma appoints Dr. Iman El-Hariry as chief medical officer. Release
> MedImmune appointed Christopher Rhodes as head of its cardiovascular and metabolic disease research unit. Release
> Fred Kurland joined Aridis Pharmaceuticals as its chief financial officer. Release
> Theravance appointed Michael Faerm as its chief business officer. Release
> The board of directors at BIO brought into its ranks Joel Marcus, the CEO of Alexandria Real Estate Equities. Release
> Liquidia Technologies named Robert Lippe as its chief operations officer. Release
> Scholar Rock appointed Paul Burgess as its vice president of intellectual property. Release
> ControlRad brought on Guillaume Baillaird as its CEO. Release
> AnaptysBio appointed Robert Hoffman as its chief financial officer. Release
> Grant Bogle joined Tesaro ($TSRO) as senior vice president and chief commercial officer. Release
> Kaiima Bio-Agritech appointed Richard Greubel as its CEO to replace Doron Gal, who will continue as president. Release
> Premier Biomedical appointed Dr. Ryan Fields to its scientific advisory board. Release
> Tristen Herrstrom was named SVP of human resources at Certara. Release
Med Tech
> Boston Scientific ($BSX) added Donna James to its board of directors. Release
Drug Delivery
> Enoch Bortey joined BioDelivery Sciences International ($BDSI) as VP of clinical biostatistics and data systems. Release
Diagnostics
> Great Basin appoints Carlos González as vice president of engineering. Release
> OncoCyte adds Andy Arno to its board of directors. Release
> MDxHealth announced that it has tapped Dr. Philip Ginsburg as its chief medical officer. Release
|